|
TRIM25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63489999999156E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.55140045044311E-10 |
| Normal-vs-Stage2 |
2.825400E-01 |
| Normal-vs-Stage3 |
6.217000E-01 |
| Normal-vs-Stage4 |
4.678200E-01 |
| Stage1-vs-Stage2 |
1.610230E-02 |
| Stage1-vs-Stage3 |
2.47959999977176E-07 |
| Stage1-vs-Stage4 |
2.17449999999619E-05 |
| Stage2-vs-Stage3 |
4.551800E-01 |
| Stage2-vs-Stage4 |
5.951000E-01 |
| Stage3-vs-Stage4 |
7.894800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.91840000000254E-05 |
| Normal-vs-AfricanAmerican |
3.974400E-02 |
| Normal-vs-Asian |
2.410000E-01 |
| Caucasian-vs-AfricanAmerican |
9.970600E-01 |
| Caucasian-vs-Asian |
6.258400E-01 |
| AfricanAmerican-vs-Asian |
6.464400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.30400000000342E-05 |
| Normal-vs-Female |
4.210900E-04 |
| Male-vs-Female |
9.762800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.571240E-01 |
| Normal-vs-Age(41-60Yrs) |
2.1360999999942E-05 |
| Normal-vs-Age(61-80Yrs) |
1.796400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.722800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.458600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.081400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.705600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.805750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.320000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.155200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.520100E-02 |
| Normal-vs-Grade 2 |
2.20389999583404E-08 |
| Normal-vs-Grade 3 |
1.876400E-02 |
| Normal-vs-Grade 4 |
7.049600E-01 |
| Grade 1-vs-Grade 2 |
5.872800E-01 |
| Grade 1-vs-Grade 3 |
5.273900E-02 |
| Grade 1-vs-Grade 4 |
2.060100E-02 |
| Grade 2-vs-Grade 3 |
1.059010E-03 |
| Grade 2-vs-Grade 4 |
1.80989999987169E-07 |
| Grade 3-vs-Grade 4 |
1.890440E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.16120052146607E-10 |
| Normal-vs-ccB subtype |
2.857600E-01 |
| ccA subtype-vs-ccB subtype |
2.82650000005269E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.435500E-02 |
| Normal-vs-N1 |
2.577600E-01 |
| N0-vs-N1 |
8.151400E-01 |
|
|
